Dynavax Technologies | Credores Comerciais



Trade Creditors Alterar Data
AbbVie 2.94B 2.66B 2024-12
Adma Biologics USD 20.22M 4.2M 2024-12
Amgen USD 2.41B 498M 2025-03
AstraZeneca 23.99B 1.44B 2025-06
Biogen USD 391.5M 32.7M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Bristol-Myers Squibb USD 5.43B 1.42B 2025-06
Dynavax Technologies USD 4.33M 4.73M 2025-03
Gilead Sciences USD 833M 70M 2024-12
Glaxosmithkline 3.46B 10.01B 2024-12
Merck USD 3.78B 295M 2025-03
Neurocrine Biosciences 110M 0 2025-03
Novartis USD 4.51B 245M 2025-06
Pfizer USD 5.24B 393M 2025-03
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Roche Holding 4.35B 828M 2024-12
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
TG Therapeutics 41.97M 34.78M 2024-09
Vertex Pharmaceuticals USD 413M 17.2M 2024-12


Dynavax Technologies Credores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.